News
Peplin `positive' on trial of sun spot treatment
A Brisbane skin-cancer biotech reports successful late-stage results for its sun-spot gel, saying it remains on schedule for a US regulatory filing and a 2011 market launch.
Australian General Manager, Peplin Inc
Dr Peter Welburn
Roles
| Role | Organisation | Sources |
|---|---|---|
| Australian General Manager | Peplin Inc | GBS Ventures (Thu 12 Nov 2009), GBS Ventures (Tue 19 May 2009), GBS Ventures (Thu 8 Jan 2009) |
Coverage
Stories naming Dr Peter Welburn. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
News
Positive Results for Peplin's Phase IIb AK Trial
Peplin reports its PEP005 gel met the primary endpoint in a Phase IIb actinic keratosis trial, clearing lesions safely across doses and moving toward Phase III development.